{
    "root": "a6e52787-dbcc-4bd0-8fa1-6875b3e80e2a",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Syfovre",
    "value": "20250506",
    "ingredients": [
        {
            "name": "Pegcetacoplan",
            "code": "TO3JYR3BOU",
            "drugbank_id": "https://go.drugbank.com/drugs/DB16694"
        },
        {
            "name": "Trehalose dihydrate",
            "code": "7YIN7J07X4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_232797"
        },
        {
            "name": "ACETIC ACID",
            "code": "Q40Q9N063P",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15366"
        },
        {
            "name": "SODIUM ACETATE",
            "code": "4550K0SC9B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32954"
        },
        {
            "name": "Sodium Hydroxide",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        }
    ],
    "indications": {
        "text": "syfovre indicated treatment geographic atrophy ( ga ) secondary age-related macular degeneration ( amd ) .",
        "doid_entities": [
            {
                "text": "age-related macular degeneration (DOID:10871)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10871"
            },
            {
                "text": "macular degeneration (DOID:4448)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4448"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "recommended dose syfovre 15 mg ( 0.1 ml 150 mg/ml solution ) administered intravitreal injection affected eye every 25 60 days . ( 2.2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": null,
    "adverseReactions": "ocular periocular infections ( 4.1 ) active intraocular inflammation ( 4.2 ) hypersensitivity ( 4.3 )",
    "indications_original": "SYFOVRE is indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).",
    "contraindications_original": "The recommended dose for SYFOVRE is 15 mg (0.1 mL of 150 mg/mL solution) administered by intravitreal injection to each affected eye once every 25 to 60 days. ( 2.2 )",
    "adverseReactions_original": "Ocular or Periocular Infections ( 4.1 ) Active Intraocular Inflammation ( 4.2 ) Hypersensitivity ( 4.3 )",
    "drug": [
        {
            "name": "Syfovre",
            "drugbank_id": "https://go.drugbank.com/drugs/DB16694"
        }
    ]
}